Announcement on Convening the Q3 2026 Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 600750 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)China Resources Jiangzhong Pharmaceutical Co., Ltd. on 6ix
Story so far
- (600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Receipt of Drug Registration Certificate for Peony and Licorice Decoction Granules
- Announcement on Obtaining the Proprietary Chinese Medicine Registration Certificate in Macao for Jianwei Xiaoshi Tablet
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
Earlier from China Resources Jiangzhong Pharmaceutical
- (600750)"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Receipt of Drug Registration Certificate for Peony and Licorice Decoction Granules
- Announcement on Obtaining the Proprietary Chinese Medicine Registration Certificate in Macao for Jianwei Xiaoshi Tablet
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on the Profit Distribution Plan for the First Half of 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
Follow China Resources Jiangzhong Pharmaceutical into a list and get an email when it puts out news.
Follow China Resources Jiangzhong Pharmaceutical